Inovio Pharma (INO) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.10 +1.85%
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +60.7%
Financial Fact:
Net loss/ (gain) attributable to non-controlling interest: 0
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $866.86 thousand versus the consensus estimate of $3.93 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Investing.com’s stocks of the week
- UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
